Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Fenwick

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Ebiomedicine|May 5, 2026
Antibody-mediated targeting of SOSIP HIV-1 Env to skin Langerhans cells potentiates humoral responsesAdele Hammoudi, Mathieu Surenaud, Jade Legros, et al.
Science Advances|April 24, 2026
Targeting PD-1<sup>+</sup> T cells with chimeric antigen receptors to reduce the HIV reservoirLaura Ermellino, Riddhima Banga, Spiros Georgakis, et al.
Nature Microbiology|July 25, 2022
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeysCraig Fenwick, Priscilla Turelli, Dongchun Ni, et al.
The Journal of Infection|October 18, 2023
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeysCraig Fenwick, Priscilla Turelli, Yoan Duhoo, et al.
Nature Communications|March 17, 2018
Sensitive and frequent identification of high avidity neo-epitope specific CD8 <sup>+</sup> T cells in immunotherapy-naive ovarian cancerSara Bobisse, Raphael Genolet, Annalisa Roberti, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2014
Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitorCraig Fenwick, Ma'an Amad, Murray D Bailey, et al.
Cell Reports|October 2, 2021
A highly potent antibody effective against SARS-CoV-2 variants of concernCraig Fenwick, Priscilla Turelli, Laurent Perez, et al.
Ebiomedicine|July 1, 2026
Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primatesRomain Marlin, Mireille Centlivre, Laetitia Bossevot, et al.
Cell Host & Microbe|September 26, 2023
Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ARTRiddhima Banga, Francesco Andrea Procopio, Erica Lana, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIsLee D Fader, Murray Bailey, Eric Beaulieu, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Ebiomedicine|May 5, 2026
Antibody-mediated targeting of SOSIP HIV-1 Env to skin Langerhans cells potentiates humoral responsesAdele Hammoudi, Mathieu Surenaud, Jade Legros, et al.
Science Advances|April 24, 2026
Targeting PD-1<sup>+</sup> T cells with chimeric antigen receptors to reduce the HIV reservoirLaura Ermellino, Riddhima Banga, Spiros Georgakis, et al.
Nature Microbiology|July 25, 2022
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeysCraig Fenwick, Priscilla Turelli, Dongchun Ni, et al.
The Journal of Infection|October 18, 2023
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeysCraig Fenwick, Priscilla Turelli, Yoan Duhoo, et al.
Nature Communications|March 17, 2018
Sensitive and frequent identification of high avidity neo-epitope specific CD8 <sup>+</sup> T cells in immunotherapy-naive ovarian cancerSara Bobisse, Raphael Genolet, Annalisa Roberti, et al.
Antimicrobial Agents and Chemotherapy|March 26, 2014
Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitorCraig Fenwick, Ma'an Amad, Murray D Bailey, et al.
Cell Reports|October 2, 2021
A highly potent antibody effective against SARS-CoV-2 variants of concernCraig Fenwick, Priscilla Turelli, Laurent Perez, et al.
Ebiomedicine|July 1, 2026
Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primatesRomain Marlin, Mireille Centlivre, Laetitia Bossevot, et al.
Cell Host & Microbe|September 26, 2023
Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ARTRiddhima Banga, Francesco Andrea Procopio, Erica Lana, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIsLee D Fader, Murray Bailey, Eric Beaulieu, et al.
Pageof 7